A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
Study sponsor: Climb Bio, Inc. · CLYM
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-09Estimated
Enrollment · participants30Estimated
Source updated2026-10-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.